Cargando…

Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer

BACKGROUND: Currently, there is no reliable blood-based marker to track tumor recurrence in endometrial cancer (EC) patients. Liquid biopsies, specifically, circulating tumor DNA (ctDNA) analysis emerged as a way to monitor tumor metastasis. The objective of this study was to examine the feasibility...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Weiwei, Jia, Nan, Jiao, Haining, Chen, Jun, Chen, Yan, Zhang, Yueru, Zhu, Menghan, Zhu, Chongying, Shen, Lifei, Long, Wenqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860194/ https://www.ncbi.nlm.nih.gov/pubmed/33536036 http://dx.doi.org/10.1186/s12967-021-02722-8

Ejemplares similares

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

Ovarian preservation for premenopausal women with early-stage endometrial cancer: a Chinese retrospective study
por: Lyu, Tianjiao, et al.
Publicado: (2019)

Comparison of survival and perioperative outcomes following simple and radical hysterectomy for stage II endometrial cancer: a single-institution, retrospective, matched-pair analysis
por: Jiang, Yahui, et al.
Publicado: (2019)

Prognostic Potential of Alternative Splicing Markers in Endometrial Cancer
por: Wang, Qian, et al.
Publicado: (2019)

Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
por: Yu, Ming, et al.
Publicado: (2021)

Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?
por: Zhu, Menghan, et al.
Publicado: (2017)

Possible Risk Factors of Pulmonary Metastases in Patients With International Federation of Gynecology and Obstetrics Stage I Endometrioid-Type Endometrial Cancer
por: Jiang, Wei, et al.
Publicado: (2017)

Signal transducer and activator of transcription family is a prognostic marker associated with immune infiltration in endometrial cancer
por: Zhou, Xin‐Ying, et al.
Publicado: (2022)

Non-Coding RNAs as Prognostic Markers for Endometrial Cancer
por: Piergentili, Roberto, et al.
Publicado: (2021)

GABPA Expression in Endometrial Carcinoma: A Prognostic Marker
por: Ma, Xiaoxue, et al.
Publicado: (2021)

Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and Progression
por: Moss, Esther L., et al.
Publicado: (2020)

Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer
por: Zheng, Hong, et al.
Publicado: (2013)

Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment
por: Oropeza-de Lara, Sergio Antonio, et al.
Publicado: (2023)

Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer
por: Grassi, Tommaso, et al.
Publicado: (2021)

Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma
por: Tian, Xiao-Peng, et al.
Publicado: (2023)

Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management
por: Hallermayr, Ariane, et al.
Publicado: (2022)

Endometrioid endometrial cancer “recurring” as high-grade serous adenocarcinoma in the inguinal lymph nodes in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?
por: Jiang, Wei, et al.
Publicado: (2019)

Focused ultrasound for safe and effective release of brain tumor biomarkers into the peripheral circulation
por: Zhu, Lifei, et al.
Publicado: (2020)

Evaluation of Vav3.1 as prognostic marker in endometrial cancer
por: Boesch, Maximilian, et al.
Publicado: (2018)

Overexpression of Nucleolin is a Potential Prognostic Marker in Endometrial Carcinoma
por: Lin, Qianhan, et al.
Publicado: (2021)

Circulating cell-free DNA and its integrity as a prognostic marker for breast cancer
por: Iqbal, Sobuhi, et al.
Publicado: (2015)

Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients
por: Liao, Hao, et al.
Publicado: (2022)

The Prognostic Value of Circulating Tumor Cells in Asian Neuroendocrine Tumors
por: Hsieh, Jason Chia-Hsun, et al.
Publicado: (2019)

Epigenetic markers in circulating cell‐free DNA as prognostic markers for survival of castration‐resistant prostate cancer patients
por: Hendriks, Rianne J., et al.
Publicado: (2018)

Evaluation of Circulating Endometrial Cells as a Biomarker for Endometriosis
por: Chen, Ying, et al.
Publicado: (2017)

Prognostic Value of Postoperative Circulating Tumor DNA in Patients With Early- and Intermediate-Stage Hepatocellular Carcinoma
por: Ye, Ke, et al.
Publicado: (2022)

Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors
por: Yan, Weiwei, et al.
Publicado: (2020)

Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.
por: Lösch, A., et al.
Publicado: (1996)

CyclinD1, a prominent prognostic marker for endometrial diseases
por: Liang, Shuo, et al.
Publicado: (2013)

Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification
por: Karnezis, Anthony N, et al.
Publicado: (2017)

Circulating microRNAs as a Fingerprint for Endometrial Endometrioid Adenocarcinoma
por: Wang, Lin, et al.
Publicado: (2014)

Evaluation of interleukins 8 and 12, CA 15-3 and free circulating DNA as prognostic markers in dogs with mammary tumors
por: Gelaleti, Gabriela B, et al.
Publicado: (2013)

Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study
por: Woo, Sang Myung, et al.
Publicado: (2021)

Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience
por: Li, Mao, et al.
Publicado: (2017)

Circulating cell-free DNA content as blood based biomarker in endometrial cancer
por: Cicchillitti, Lucia, et al.
Publicado: (2017)

Prognostic and clinicopathological significance of circulating tumor cells in osteosarcoma
por: Li, Minghui, et al.
Publicado: (2019)

Circulating tumor cells as a prognostic and predictive marker in gastrointestinal stromal tumors: a prospective study
por: Li, Qiang, et al.
Publicado: (2016)

The prognostic value of longitudinal circulating tumor DNA profiling during osimertinib treatment
por: Ma, Shenglin, et al.
Publicado: (2021)

Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer
por: Gao, Yang, et al.
Publicado: (2016)

Programmed Death Ligand 1: A Poor Prognostic Marker in Endometrial Carcinoma
por: Chew, Mianxin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3cio50uhj3dthk4fcihaassoe4